Market Context
The broad-market trend is constructive, while the current market pulse is adverse and the market-risk posture is defensive. The current Healthcare sector pulse is constructive, while its short-term outlook is mixed, with no clear directional read. That current reading differs from the forward sector outlook. Broad-market measures include breadth of 39.13%, capitalization-weighted return of 0.48%, and equal-weight return of -0.54%. Healthcare measures include breadth of 53.08%, capitalization-weighted return of -0.22%, and equal-weight return of 0.13%.
LIVN — LivaNova PLC
WATCH LONG | October 19, 2026
Setup
LIVN remains a WATCH long setup, with the preferred entry zone anchored to established support.
Key Levels
- Reference Price (as of October 19, 2026): $78.31
- Analyst Consensus Target: $90.55
- Reference upside: 15.64%
- Reference reward/risk: 5.08
- Preferred Entry Zone: $75.90–$80.32
- Entry Risk: 3.08% from entry
Why It Stands Out
Upward stock-level model direction across the immediate, near-term, medium-term, and longer-term horizons provides substantive support. Additional support comes from the fundamental profile and a defined reward/risk profile.
Risk & Timing
Forward sector conditions remain a headwind: the near-term outlook is adverse.
Bottom Line
LIVN remains a WATCH long setup. Technical trend conditions remain the principal reason the setup is classified WATCH.
Research Snapshot
Valuation & Fundamentals
Valuation measures include trailing P/E of 22.95x and forward P/E of 16.00x. Profitability measures include ROA of 5.04%, ROE of 15.40%, operating margin of 13.50% and net margin of 12.80%. Balance-sheet and volatility context includes total liabilities to equity of 1.17 and beta of 0.88. The Fundamental Sentiment Score is 0.49.
Technical Context
Historical ranges include 21-day range of $74.23–$79.31, 40-day range of $74.11–$81.83 and 52-week range of $48.82–$85.76.
Risks & Catalysts
Earnings are estimated for November 4, 2026 and remain an event risk.
